𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Disadvantages of peginterferon and ribavirin treatment in older patients with chronic hepatitis C: an analysis using the propensity score

✍ Scribed by Hirotoshi Ebinuma, Hidetsugu Saito, Shinichiro Tada, Nobuhiro Nakamoto, Tazuko Ohishi, Satoshi Tsunematsu, Naoki Kumagai, Kanji Tsuchimoto, Nobuhiro Tsukada, Yasutaka Inagaki, Yoshinori Horie, Masahiko Takahashi, Kazuhiro Atsukawa, Yukishige Okamura, Takanori Kanai, et al

Book ID
118822605
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
512 KB
Volume
6
Category
Article
ISSN
1936-0533

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of peginterferon alp
Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C
✍ Richard Njouom; MichΓ¨le Tagni Sartre; Isabelle Timba; Eric Nerrienet; Patrice Tc πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

## Abstract Data were examined from a day‐to‐day clinical practice in Yaounde, Cameroon to evaluate the efficacy and safety of peginterferon alfa‐2a and ribavirin in treatment‐naive Cameroonian patients with chronic hepatitis C. Ninety adults with chronic hepatitis C (mean age, 53 ± 8 years; 79% ma